Long Island Jewish Medical Center — New Hyde Park, New York

Long Island Jewish Medical Center is a clinical research site located in New Hyde Park, New York, United States 11040.

Crixeo Clinical Trials Trust Score: 34/100 (FAILING). This profile has not yet been claimed by the site owner.

Long Island Jewish Medical Center has participated in 240 clinical trials with 50 currently active.

Therapeutic areas: Cystic Fibrosis, Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma.

Sponsors: Merck Sharp & Dohme LLC, National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in New Hyde Park

Browse all research sites in New York · View every site in New Hyde Park

Sponsor Feasibility Report

Trust Score: 34/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Long Island Jewish Medical Center?

Long Island Jewish Medical Center has a Crixeo Trust Score of 34/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Long Island Jewish Medical Center conducted?

Long Island Jewish Medical Center has 240 clinical trials on record, with 50 currently active. Their work covers Cystic Fibrosis, Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma.

Is Long Island Jewish Medical Center accredited by Crixeo Clinical Trials?

Long Island Jewish Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Long Island Jewish Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.